Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma-Associations with tumor phenotype and survival-Reference-Cited by-同舟云学术

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma-Associations with tumor phenotype and survival

Published:2014-11-11 Issue:5 Volume:121 Page:697-707
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Tilan Jason U.¹²,Krailo Mark³,Barkauskas Donald A.³,Galli Susana⁴,Mtaweh Haifa⁵,Long Jessica⁵,Wang Hongkun⁶,Hawkins Kirsten⁵,Lu Congyi⁷,Jeha Dima⁴,Izycka-Swieszewska Ewa⁸,Lawlor Elizabeth R.⁹¹⁰,Toretsky Jeffrey A.¹¹,Kitlinska Joanna B.⁴

Affiliation:

1. Department of Nursing; School of Nursing and Health Studies, Georgetown University; Washington District of Columbia

2. Department of Human Science; School of Nursing and Health Studies, Georgetown University; Washington District of Columbia

3. Department of Preventive Medicine; Keck School of Medicine of the University of Southern California; Los Angeles California

4. Department of Biochemistry and Molecular and Cellular Biology; Georgetown University Medical Center; Washington District of Columbia

5. Department of Pediatrics; Georgetown University Medical Center; Washington District of Columbia

6. Department of Biostatistics and Bioinformatics; Georgetown University Medical Center; Washington District of Columbia

7. McGovern Institute; Massachusetts Institute of Technology; Boston Massachusetts

8. Department of Pathology and Neuropathology; Medical University of Gdansk; Poland

9. Department of Pediatrics; University of Michigan; Ann Arbor Michigan

10. Department of Pathology; University of Michigan; Ann Arbor Michigan

11. Department of Oncology; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center; Washington District of Columbia

Funder

National Institutes of Health

Children's Cancer Foundation

Aflac

Burroughs Wellcome Fund

WWWW (QuadW) Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial;Ladenstein;J Clin Oncol.,2010

2. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group;Womer;J Clin Oncol.,2012

3. Ewing's sarcoma family of tumors: current management;Bernstein;Oncologist.,2006

4. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group;Doorninck;J Clin Oncol.,2010

5. Round cell sarcomas beyond Ewing: emerging entities;Antonescu;Histopathology.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies;International Journal of Molecular Sciences;2023-06-09

2. Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship;Molecular Cancer;2023-03-13

3. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread;Journal of Cancer Research and Clinical Oncology;2022-12-30

4. Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma;Nature Communications;2022-04-28

5. NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer;Scientific Reports;2022-02-04